BK
74
2
AON
54
2
F
58
11
ORCL
65
-2
BA
54
5
CCI
31
3
NAVI
52
5
GS
75
2
PBI
69
4
CVX
47
3
PFG
45
3
CTSH
56
2
ADT
53
3
HST
49
-9
HPQ
63
6
CINF
53
2
HPE
63
2
PPL
54
-5
KEY
46
3
VMC
57
4
BK
74
2
AON
54
2
F
58
11
ORCL
65
-2
BA
54
5
CCI
31
3
NAVI
52
5
GS
75
2
PBI
69
4
CVX
47
3
PFG
45
3
CTSH
56
2
ADT
53
3
HST
49
-9
HPQ
63
6
CINF
53
2
HPE
63
2
PPL
54
-5
KEY
46
3
VMC
57
4
Financhill
Back

Avid Bioservices 10K Form

Buy
65

CDMO
Avid Bioservices

Last Price:
12.29
Seasonality Move:
79.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CDMO News And Ratings

See the #1 stock for the next 7 days that we like better than CDMO

CDMO Financial Statistics

Sales & Book Value

Annual Sales: $139.91M
Cash Flow: $-4.99M
Price / Cash Flow: 0
Annual Sales: $0.92
Price / Book: 13.38

Profitability

EPS (TTM): -2.27000
Net Income (TTM): $-144.17M
Gross Margin: $7.32M
Return on Equity: -106.95%
Return on Assets: -35.62%

Avid Bioservices Earnings Forecast

Key Avid Bioservices Financial Ratios

  • The Gross Profit Margin over the past 30 years for CDMO is 5.23%.
  • The Selling, General & Administrative Expenses for CDMO have been equal to 18.58% of Gross Profit Margin.
  • The Research & Development expenses have been 49.11% of Revenue.
  • The Interest Expense is -3.08% of Operating Income.
  • The Net Earning history of CDMO is -100.60% of Total Revenues.
  • Per Share Earnings over the last 30 years have been positive in 19 years.

Avid Bioservices Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CDMO
CUSIP: 05368M
Website: avidbio.com

Debt

Debt-to-Equity Ratio: 2.62
Current Ratio: 1.46
Quick Ratio: 0.96

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 194.22

CDMO Technical Analysis vs Fundamental Analysis

Buy
65
Avid Bioservices (CDMO) is a Buy

Is Avid Bioservices a Buy or a Sell?

  • Avid Bioservices stock is rated a Buy
    The current Avid Bioservices [CDMO] share price is $12.30. The Score for CDMO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.